Delineate is a startup based in unknown. Brouky records 1 investor associated with the company.
Delineate builds AI agents to accelerate and improve the design of clinical trials by optimizing trial plans, targeting a $10B market where time savings translate to significant revenue gains.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.